AlphaCrest Capital Management LLC - BLUEPRINT MEDICINES CORP ownership

BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 278 filers reported holding BLUEPRINT MEDICINES CORP in Q4 2020. The put-call ratio across all filers is 4.17 and the average weighting 0.2%.

Quarter-by-quarter ownership
AlphaCrest Capital Management LLC ownership history of BLUEPRINT MEDICINES CORP
ValueSharesWeighting
Q3 2022$411,000
+66.4%
6,236
+27.7%
0.02%
+108.3%
Q2 2022$247,000
-48.2%
4,883
-34.6%
0.01%
-55.6%
Q1 2022$477,000
+89.3%
7,467
+160.7%
0.03%
+145.5%
Q2 2021$252,000
-85.8%
2,864
-84.3%
0.01%
-88.9%
Q1 2021$1,779,000
+80.1%
18,296
+107.7%
0.10%
+20.7%
Q4 2020$988,000
+81.6%
8,810
-5.3%
0.08%
+24.2%
Q1 2020$544,0009,3000.07%
Other shareholders
BLUEPRINT MEDICINES CORP shareholders Q4 2020
NameSharesValueWeighting ↓
Aquilo Capital Management, LLC 645,539$69,144,0007.84%
DAFNA Capital Management LLC 206,911$22,162,0005.57%
Eagle Health Investments LP 192,639$20,634,0005.03%
Casdin Capital, LLC 1,550,000$166,021,0004.68%
CADIAN CAPITAL MANAGEMENT, LP 450,657$48,270,0002.65%
Avidity Partners Management LP 995,000$106,574,0002.26%
Integral Health Asset Management, LLC 75,000$8,033,0002.22%
Rock Springs Capital Management LP 859,755$92,088,0002.13%
Boxer Capital, LLC 507,374$54,345,0002.11%
EFG Asset Management (North America) Corp. 112,715$12,082,0001.58%
View complete list of BLUEPRINT MEDICINES CORP shareholders